These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment. Coles CL; Mabula K; Seidman JC; Levens J; Mkocha H; Munoz B; Mfinanga SG; West S Clin Infect Dis; 2013 Jun; 56(11):1519-26. PubMed ID: 23487375 [TBL] [Abstract][Full Text] [Related]
3. Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae. Batt SL; Charalambous BM; Solomon AW; Knirsch C; Massae PA; Safari S; Sam NE; Everett D; Mabey DC; Gillespie SH Antimicrob Agents Chemother; 2003 Sep; 47(9):2765-9. PubMed ID: 12936971 [TBL] [Abstract][Full Text] [Related]
7. Mass azithromycin distribution and emerging resistance: taking a minimum harms approach. Malhotra-Kumar S; Goossens H Clin Infect Dis; 2013 Jun; 56(11):1527-9. PubMed ID: 23487372 [No Abstract] [Full Text] [Related]
8. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Leach AJ; Shelby-James TM; Mayo M; Gratten M; Laming AC; Currie BJ; Mathews JD Clin Infect Dis; 1997 Mar; 24(3):356-62. PubMed ID: 9114185 [TBL] [Abstract][Full Text] [Related]
9. Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year. Gaynor BD; Holbrook KA; Whitcher JP; Holm SO; Jha HC; Chaudhary JS; Bhatta RC; Lietman T Br J Ophthalmol; 2003 Feb; 87(2):147-8. PubMed ID: 12543738 [TBL] [Abstract][Full Text] [Related]
10. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. Fry AM; Jha HC; Lietman TM; Chaudhary JS; Bhatta RC; Elliott J; Hyde T; Schuchat A; Gaynor B; Dowell SF Clin Infect Dis; 2002 Aug; 35(4):395-402. PubMed ID: 12145722 [TBL] [Abstract][Full Text] [Related]
11. [Bacteremia and meningitis caused by Streptococcus pneumoniae during treatment with azithromycin]. Lisby JG; Brasholt M; Teglbjoerg LL Ugeskr Laeger; 2002 May; 164(20):2629. PubMed ID: 12043408 [TBL] [Abstract][Full Text] [Related]
12. The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma. Haug S; Lakew T; Habtemariam G; Alemayehu W; Cevallos V; Zhou Z; House J; Ray K; Porco T; Rutar T; Keenan J; Lietman TM; Gaynor BD Clin Infect Dis; 2010 Sep; 51(5):571-4. PubMed ID: 20649409 [TBL] [Abstract][Full Text] [Related]
13. Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control? West SK; Moncada J; Munoz B; Mkocha H; Storey P; Hardick J; Gaydos CA; Quinn TC; Schachter J J Infect Dis; 2014 Jul; 210(1):65-71. PubMed ID: 24446528 [TBL] [Abstract][Full Text] [Related]
14. Simplification and improvement of height-based azithromycin treatment for paediatric trachoma. Basilion EV; Kilima PM; Mecaskey JW Trans R Soc Trop Med Hyg; 2005 Jan; 99(1):6-12. PubMed ID: 15550255 [TBL] [Abstract][Full Text] [Related]
18. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma. Bowman RJ; Sillah A; Van Dehn C; Goode VM; Muqit MM; Johnson GJ; Milligan P; Rowley J; Faal H; Bailey RL Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4074-9. PubMed ID: 11095598 [TBL] [Abstract][Full Text] [Related]
19. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Lietman T; Porco T; Dawson C; Blower S Nat Med; 1999 May; 5(5):572-6. PubMed ID: 10229236 [TBL] [Abstract][Full Text] [Related]